This is a molecule-level guide to semaglutide in British Columbia. Rather than focusing on a single brand, I cover how to choose between Ozempic, Wegovy, Rybelsus and the newly launched generic, when British Columbians can now get generic semaglutide at their pharmacy, why compounded semaglutide is not legal in Canada, and what the clinical evidence says. Pricing reflects April 2026 quotes.
If you already know which brand you need, jump to our Ozempic in British Columbia guide for diabetes details or our Wegovy in British Columbia guide for weight-management details. For the full semaglutide overview, see our complete semaglutide guide.
What Semaglutide Means for British Columbia Patients
Semaglutide is the active pharmaceutical ingredient in three Health Canada-approved brand products plus the newly launched generic [1]:
- Ozempic (injectable, 0.25 to 2.0 mg weekly). On-label for type 2 diabetes. Widely prescribed off-label for weight loss. Cash price $250 to $375 per month in British Columbia.
- Wegovy (injectable, 0.25 to 2.4 mg weekly). On-label for chronic weight management (BMI 30+, or 27+ with comorbidity). Cash price $376 to $493 per month. Higher dose, higher price.
- Rybelsus (oral tablet, 3, 7 or 14 mg daily). On-label for type 2 diabetes. The oral formulation. Cash price roughly $250 to $300 per month.
- Generic semaglutide (injectable, launched May 2026 for diabetes). Manufactured by Apotex (Apo-Semaglutide) and Dr. Reddy's, with Sandoz, Teva Canada and others still under Health Canada review. Cash pharmacy price $88 to $120 per month for diabetes doses; $150 to $250 per month for the future 2.4 mg weight-management dose (Wegovy-equivalent), expected in late 2026 or early 2027 pending Health Canada approval.
In British Columbia, the brand you receive depends on your indication (diabetes vs weight management), your prescriber’s preference, public plan coverage and the price your insurance or wallet can absorb. More on each below.
Semaglutide Products Available in British Columbia
Every major pharmacy chain in British Columbia stocks all three brand semaglutide products as of April 2026 [2]. The table below summarizes how each compares for British Columbians.
| Product | Form | Indication | Typical Monthly Cost (April 2026) | Public Plan Status |
|---|---|---|---|---|
| Ozempic | Injectable (0.25 to 2.0 mg) | Type 2 diabetes (off-label for weight loss) | $250 to $375 | BC PharmaCare Special Authority |
| Wegovy | Injectable (0.25 to 2.4 mg) | Chronic weight management | $376 to $493 | Not covered |
| Rybelsus | Oral tablet (3, 7 or 14 mg) | Type 2 diabetes | $250 to $300 | BC PharmaCare Special Authority |
| Generic semaglutide | Injectable (various) | Diabetes first, weight management later | $88 to $120 | Under formulary review (2026–2027) |
Choosing Your Semaglutide Product in British Columbia
Here’s a quick decision framework British Columbians can use. Your prescribing clinician makes the final call.
If you have type 2 diabetes
Ozempic is the default because BC PharmaCare lists it as a Special Authority benefit, your co-pay is typically the cheapest of the three brand options, and the weekly injection is convenient. Rybelsus is useful if you prefer an oral tablet or have a needle aversion. Generic semaglutide is now available in Canada from Apotex (Dr. Reddy's has been off the market since an August 2026 recall), so expect your prescription to be switchable. See our Ozempic in British Columbia guide for province-specific diabetes coverage details.
If you have obesity and a BMI of 30 or higher
Wegovy is the Health Canada-approved product. BC PharmaCare does not cover Wegovy, so your best path to a lower monthly cost is private insurance with prior authorization. Some patients use off-label Ozempic because it is cheaper, but the 2.4 mg dose is only validated in the STEP trials for Wegovy. See our Wegovy in British Columbia guide for province-specific weight-loss prior-auth details.
If you want the cheapest legal option
Consider generic semaglutide. It launched in Canadian pharmacies in May 2026 at about $88 to $120 per month for the diabetes dose [3]. Generic semaglutide (Apotex's Apo-Semaglutide; Dr. Reddy's has been off the market since an August 2026 recall) is now the cheapest cash option in British Columbia at roughly $88 to $99 per month at Costco Pharmacy, well below brand Ozempic at $250 to $310.
Generic Semaglutide Launch in British Columbia
Novo Nordisk’s Canadian data exclusivity on semaglutide expired on January 4, 2026 [4]. Health Canada has now authorized two generic manufacturers, Dr. Reddy's Laboratories (April 28, 2026) and Apotex Inc. (May 1, 2026). Additional applications from Sandoz, Teva Canada and other manufacturers remain under review. Both reached Canadian pharmacies in the type 2 diabetes indication (Ozempic-equivalent) in May 2026, though Dr. Reddy's has since been off the market after an August 2026 recall, followed by a 2.4 mg weight-management generic in late 2026 or early 2027, with generic cash prices expected to ease further as more manufacturers launch and several provinces review the generic for public-plan coverage [3].
Costco Metro Vancouver, Costco Victoria and London Drugs are expected to be first-to-market for generic semaglutide in BC, driven by scale and favourable wholesale contracts.
For the national timeline and manufacturer detail, read our generic semaglutide guide.
Compounded Semaglutide: Not a Legal Option in British Columbia
Health Canada prohibits the compounding of semaglutide by community pharmacies [5]. Any website or clinic advertising "compounded semaglutide" in British Columbia is operating outside Canadian drug-safety regulation. Product purity, sterility and potency cannot be verified. Serious adverse events have been reported in the U.S. from compounded GLP-1 use.
- Compounded semaglutide has not been reviewed by Health Canada for safety, quality or efficacy.
- Health Canada issued public warnings against compounded weight-loss drugs in 2023 and 2024.
- Provincial colleges of pharmacists in British Columbia prohibit licensed pharmacies from dispensing compounded semaglutide.
If you encounter a telehealth service offering "compounded semaglutide" in British Columbia, it is either (a) not operating legally in Canada or (b) referring you to an unregulated U.S. source. Stick with Health Canada-approved Ozempic, Wegovy, Rybelsus or now-available generic semaglutide.
Telehealth vs In-Person Semaglutide in British Columbia
Both paths are widely available to British Columbians. Here’s how the six Canadian telehealth services compare.
Top pick: BirchRx is our highest-rated Canadian GLP-1 provider for 2026 (9.5/10) if you live in Ontario, British Columbia, Alberta or Saskatchewan. The assessment is free and you pay nothing unless a licensed Canadian physician approves you, so month one costs $149 against $308 at MyRocky and $248 at Felix. Ongoing months are $199, everything included. See if you qualify or read our full BirchRx review. Outside those four provinces, or if you want a brand-name GLP-1, MyRocky (9.1/10) is the pick: a one-time $99 consult covers lab work, generic semaglutide runs $149 a month plus a $60 monthly program fee, and it serves all 10 provinces from its own LegitScript-certified pharmacy in Mississauga. Across a full year BirchRx also costs less, roughly $2,338 against $2,607 once MyRocky’s $60 monthly program fee is counted. Visit MyRocky.
| Provider | Monthly Program Cost | Consultation Fee | Coverage | Learn More |
|---|---|---|---|---|
| BirchRx ⭐ Top Pick (ON, BC, AB, SK) | $149 first month, then $199 | Free assessment, pay only if approved | ON, BC, AB and SK only | Visit BirchRx |
| MyRocky (best 12-month value) | Generic $149 + $60/mo fee | $99 once + $60/mo program fee | All 10 provinces | Visit MyRocky |
| Felix Health | Generic $149/pen | Free visit; $40 follow-ups as needed | All provinces except QC | Visit Felix |
| Maple | Via pharmacy | $69 per consult | All provinces | Visit Maple |
| Hims Canada | From $149 | Included | Select provinces | Visit Hims |
| Jill Health | Pricing on assessment | Included in program | Most provinces | Visit Jill |
| DooU | Pricing on assessment | Included in program | Most provinces | Visit DooU |
| Raven | Pricing on assessment | Included in program | Most provinces | Visit Raven |
Provider reviews: BirchRx (top pick in ON, BC, AB and SK), MyRocky (best value nationwide), Felix, Maple, Hims Canada, Jill Health, DooU and Raven.
All six telehealth services on this list accept new patients from British Columbia as of April 2026.
Cost of Semaglutide in British Columbia
Your monthly cost depends on which product you take and where you fill it. Quick overview for British Columbia:
- Ozempic 1.0 mg: $250 to $375 per month brand cash; Costco is cheapest at about $250 to $265.
- Wegovy 2.4 mg: $376 to $493 per month brand cash; Costco is cheapest at $376 to $493.
- Rybelsus 14 mg: $250 to $300 per month brand cash; similar to Ozempic pricing.
- Generic semaglutide (now available for diabetes): $88 to $120 per month depending on indication and dose.
For in-depth pharmacy-by-pharmacy pricing, see the brand-specific pages: Ozempic in British Columbia and Wegovy in British Columbia. For national pricing comparison, see our semaglutide cost guide.
Clinical Evidence Behind Semaglutide for British Columbians
Semaglutide has the strongest randomized-trial evidence base of any GLP-1 receptor agonist. Key studies that inform prescribing in British Columbia:
- SUSTAIN-6 (2016). Injectable semaglutide (Ozempic) reduced major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease [6].
- STEP 1 (2021). Semaglutide 2.4 mg (Wegovy) produced a mean weight loss of roughly 14.9 percent over 68 weeks in adults with obesity, vs 2.4 percent on placebo [7].
- SELECT (2023). Semaglutide 2.4 mg reduced major adverse cardiovascular events by 20 percent in adults with overweight or obesity and established cardiovascular disease, without type 2 diabetes [8].
- PIONEER program. Oral semaglutide (Rybelsus) showed non-inferior HbA1c reduction vs injectable in type 2 diabetes patients, at the cost of a small absorption window around dosing.
FAQ
Is semaglutide the same as Ozempic in British Columbia?
Semaglutide is the active ingredient. Ozempic is a Health Canada-approved brand of injectable semaglutide for type 2 diabetes. Wegovy is the higher-dose brand for weight management. Rybelsus is the oral tablet. All three are sold across British Columbia.
Is generic semaglutide available in British Columbia?
Yes. Apotex's Apo-Semaglutide Injection launched in Canadian pharmacies in May 2026 and remains supplied, while Dr. Reddy's generic has been off the market since an August 2026 recall. Costco has the lowest cash price at roughly $88 to $99 per month. The 2.4 mg weight-management dose (Wegovy-equivalent) is still expected in late 2026 or early 2027.
Can I buy compounded semaglutide in British Columbia?
No. Health Canada and provincial colleges of pharmacists prohibit compounded semaglutide. Any service offering it in British Columbia is operating outside Canadian drug-safety regulation. Stick with Health Canada-approved Ozempic, Wegovy, Rybelsus or the now-available generic.
Which semaglutide product is cheapest in British Columbia today?
For type 2 diabetes, Ozempic at Costco pharmacy runs about $250 to $265 per month in British Columbia. For weight management, Wegovy at Costco runs $376 to $493 per month. Generic semaglutide already undercuts both, available since May 2026.
Is oral semaglutide (Rybelsus) covered by BC PharmaCare?
BC PharmaCare lists Rybelsus as a Special Authority benefit for type 2 diabetes. Coverage conditions mirror those for injectable Ozempic. Weight-management use is never covered.
How has semaglutide supply in British Columbia changed since 2024?
Metro Vancouver and Victoria pharmacies faced intermittent Ozempic shortages in 2023 and 2024 tied to cross-border export demand. Supply stabilized by mid-2025.
Can a telehealth service prescribe any semaglutide product in British Columbia?
Yes, in most cases. British Columbians can access Ozempic, Wegovy and Rybelsus through Canadian telehealth services after an online assessment. All six Canadian telehealth services on this list serve British Columbia.
This article is informational and is not a substitute for medical advice from your prescribing clinician. Always confirm pricing directly with the pharmacy before filling.
Sources
- Health Canada: Semaglutide (Ozempic, Wegovy, Rybelsus) Product Monographs: Official Canadian product monographs for all three Health Canada-approved semaglutide brands.
- BC PharmaCare Limited Coverage Drugs Program: Official Program Information: Provincial drug plan rules and formulary lookup for British Columbia.
- Patented Medicine Prices Review Board: Generic Drug Pipeline (2026): Industry reporting on generic semaglutide submissions under Health Canada review.
- Semaglutide Canada: Generic Semaglutide in Canada: Full national timeline on generic semaglutide launch, manufacturers and pricing.
- Health Canada: Advisory on Compounded Semaglutide and Other Weight-Loss Products: Public warnings on unauthorized compounded semaglutide products and related safety concerns.
- SUSTAIN-6: Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes (NEJM, 2016): Landmark cardiovascular outcomes trial for Ozempic.
- STEP 1: Once-Weekly Semaglutide in Adults with Overweight or Obesity (NEJM, 2021): Landmark randomized trial establishing Wegovy efficacy for chronic weight management.
- SELECT: Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (NEJM, 2023): Landmark trial showing cardiovascular benefit of Wegovy in non-diabetic adults with obesity.
- Drug Shortages Canada: Health Canada-run site tracking current semaglutide supply status across Canada.
- Canadian Agency for Drugs and Technologies in Health (CADTH): Semaglutide Reimbursement Review: CADTH reimbursement guidance used by provincial drug plans for semaglutide.